Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Autologous Adipose Derived Regenerative Cells Treatment of Autoimmune Determined Refractory Epilepsy - Evaluation of Safety and Efficacy

NCT03676569 is registered in ClinicalTrials.gov with Mossakowski Medical Research Centre Polish Academy of Sciences as lead sponsor.

NCT NCT03676569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Autologous Adipose Derived Regenerative Cells Treatment of Autoimmune Determined Refractory Epilepsy - Evaluation of Safety and Efficacy
Lead sponsor
Mossakowski Medical Research Centre Polish Academy of Sciences
Phase
Phase 1
Overall status
Completed
Start date
November 15, 2015
Completion date
April 14, 2019
Enrollment
6 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy